Get the Stockscreener App
0.2382
0.75%
-0.0018
Bionano Genomics Inc stock is traded at $0.2382, with a volume of 2.13M.
It is down -0.75% in the last 24 hours and down -22.11% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
See More
Previous Close:
$0.24
Open:
$0.2401
24h Volume:
2.13M
Relative Volume:
0.93
Market Cap:
$24.80M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.0149
EPS:
-16.0015
Net Cash Flow:
$-126.87M
1W Performance:
+13.75%
1M Performance:
-22.11%
6M Performance:
-77.74%
1Y Performance:
-84.43%
1-Day Range:
$0.2311
$0.2554
1-Week Range:
$0.20
$0.268
52-Week Range:
$0.20
$2.27
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
0.2382 | 24.80M | 36.12M | -232.49M | -126.87M | -16.00 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bionano Genomics stock hits 52-week low at $0.2 By Investing.com - Investing.com Australia
Bionano Genomics stock hits 52-week low at $0.2 - Investing.com
BNGO (Bionano Genomics) Accumulated other comprehensive inc - GuruFocus.com
BNGO (Bionano Genomics) 50-Day SMA : $0.35 (As of Nov. 20, 2024) - GuruFocus.com
BNGO (Bionano Genomics) 6-Month Price Index : 0.20 (As of Nov. 20, 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Operating Margin % : -372.57% (As of Sep. 2024) - GuruFocus.com
BTIG maintains neutral on BNGO shares amid Q3 results and strategy shift - Investing.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Quarterly 10-Q Report - Quartzy
Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) - MSN
Bionano Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $0.26 By Investing.com - Investing.com Australia
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... By GuruFocus - Investing.com Canada
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance
Optical Genome Mapping Market Size, Share, Trends, - openPR
Bionano Genomics Sees Growth in OGM Adoption - TipRanks
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript - MSN
Bionano Genomics Q3 Revenue Falls 35% Despite OGM System Growth; Reports Mixed Results | BNGO Stock News - StockTitan
Bionano Genomics stock hits 52-week low at $0.26 - Investing.com
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 - Barchart
Earnings Outlook For Bionano Genomics - Benzinga
U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.67% - Investing.com
Asia stocks fall as China stimulus disappoints, deflation persists - Investing.com
XRP Climbs 10.07% In Bullish Trade - Investing.com UK
Bionano Genomics Inc (BNGO): Major Improvements, Worth A Look - Stocks Register
Bionano Genomics (BNGO) Sets Q3 2024 Earnings Call for November 13 | BNGO Stock News - StockTitan
Optical Genome Mapping Market to Witness 26.76% CAGR During - GlobeNewswire
Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030Consumables and Reagents to Register High GrowthBionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry - Yahoo Canada Finance
Bionano Genomics Announces $3 Million Registered Direct OfferingSAN DIEGO, Oct. 31, 2024 – Bionano Genomics, Inc. (Nasdaq: BNGO) recently finalized a definitive agreement with institutional investors for a registered direct offering. The of - Defense World
Bionano Genomics stock hits 52-week low at $0.27 By Investing.com - Investing.com Australia
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Genomics stock hits 52-week low at $0.27 - Investing.com India
BioNano Genomics Announces $3M Direct Offering Initiative - TipRanks
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - The Manila Times
Waste Management (WM-N) QuotePress Release - The Globe and Mail
Bionano Genomics (STU:2Y30) Pre-Tax Income : €-189.69 Mil (TTM As of Jun. 2024) - GuruFocus.com
S&P 500 valuation suggests 1-2% price return over next decade: BofA - Investing.com
10 Best Penny Stocks to Invest in 2024 - Techopedia
Bionano Genomics' OGM outperforms in MYC gene study - Investing.com
Bionano Genomics' OGM outperforms in MYC gene study By Investing.com - Investing.com Canada
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma - StockTitan
Analysts Predict How High Bionano Genomics Inc (BNGO) Will Go. - Stocks Register
Bionano Genomics stock hits 52-week low at $0.3 amid market challenges - Investing.com
Taking on analysts’ expectations and winning: Bionano Genomics Inc (BNGO) - SETE News
BNGO Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Bionano Genomics Inc (BNGO) deserves closer scrutiny - US Post News
Stock market today: S&P 500 closes above 5,800 for first time ever as banks rally - Investing.com
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):